New Leaf Funds performance summary (NLV-I & NLV-II) with capital commitments and IRR metricsFund Performance Data for New Leaf and Sprout Healthcare Funds (2014)
Case Filekaggle-ho-024031House OversightSprout Capital Healthcare Technology Portfolio Performance Summary
Unknown1p1 persons
Case File
kaggle-ho-024031House OversightSprout Capital Healthcare Technology Portfolio Performance Summary
Sprout Capital Healthcare Technology Portfolio Performance Summary The passage provides internal performance metrics for a venture capital fund with no mention of influential public officials, controversial actions, or financial flows tied to power centers. It lacks actionable leads for investigative follow‑up. Key insights: Sprout Funds invested $1.019 billion in 69 healthcare tech companies (1995‑2013).; Generated $1.997 billion in realized returns plus $68 million unrealized.; Reported IRR outperformance versus major public indices (e.g., +638 bps vs S&P 500 for Sprout IX).
Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024031
Pages
1
Persons
1
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
Advertisement
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.